Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2024.03.29
Z6尊龙:董事会对自力董事自力性评估的专项意见
2024.03.29
Z6尊龙:2023年度内部控制评价报告
2024.03.29
Z6尊龙:2023年度监事会事情报告
2023.12.18
Z6尊龙:公司章程
2023.11.21
公司章程
2021.12.11
自力董事关于第五届董事会第十五次聚会相关事项的自力意见
2021.10.16
自力董事关于第五届董事会第十二次聚会相关事项的自力意见
2021.08.27
公司章程(2021年8月)
2021.08.27
自力董事关于控股股东及其他关联方占用公司资金、公司对外担保情形的专项说明和自力意见
2021.07.24
自力董事关于第五届董事会第十次聚会相关事项的自力意见
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】